![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (S.J., D.M., V.R.); Department of Pharmacology, Georgetown University, Washington, DC (S.P.); and Gunma University School of Medicine, Maebashi, Japan (Y.S.)
Pertussis toxin ADP ribosylates Gi and Go transducing proteins and functionally uncouples adenosine A1 receptor (A1AR) from its effectors. We hypothesized that this loss in receptor coupling could lead to de novo A1AR synthesis by the cell in a futile attempt to re-establish normal receptor function. To test this hypothesis, we used hamster ductus deferens tumor (DDT1 MF-2) cells, a cell culture model for studying A1AR, and showed that pertussis toxin (100 ng/ml) produced a time-dependent loss in A1AR-Gi interaction and abolished A1AR activation of extracellular signal-regulated kinase 1/2. Interestingly, pertussis toxin increased the expression of A1AR, as measured by real-time polymerase chain reaction, immunocytochemistry, and [3H]cyclopentyl-1,3-dipropylxanthine (DPCPX) binding, suggesting a compensatory response to Gi protein inactivation. DDT1 MF-2 cells exposed to pertussis toxin demonstrated nuclear factor
B (NF-
B) activation within 30 min of exposure, a time point that preceded the loss of function of the A1AR. Inhibition of NF-
B attenuated the increase in A1AR induced by pertussis toxin. Cells exposed to B-oligomer subunit of pertussis toxin, devoid of significant ADP ribosyltransferase activity, showed increased A1AR protein expression, preceded by activation of NF-
B. B-Oligomer increased intracellular Ca2+ in DDT1 MF-2 cells. Chelation of intracellular Ca2+ with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid or inhibition of protein kinase C (PKC) with bisindolylmaleimide hydrochloride reduced the activation of NF-
B and [3H]DPCPX binding. We conclude that pertussis toxin promotes de novo A1AR synthesis by activating NF-
B through an ADP ribosylation-independent mechanism involving intracellular Ca2+ release and PKC activation.
Address correspondence to: Dr. Vickram Ramkumar, Southern Illinois University School of Medicine, P.O. Box 19629, Springfield, IL 62794-9629. E-mail: vramkumar{at}siumed.edu
This article has been cited by other articles:
![]() |
I. Zanotti, F. Poti, M. Pedrelli, E. Favari, E. Moleri, G. Franceschini, L. Calabresi, and F. Bernini The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential J. Lipid Res., May 1, 2008; 49(5): 954 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Pingle, S. Jajoo, D. Mukherjea, L. F. Sniderhan, K. A. Jhaveri, A. Marcuzzi, L. P. Rybak, S. B. Maggirwar, and V. Ramkumar Activation of the Adenosine A1 Receptor Inhibits HIV-1 Tat-Induced Apoptosis by Reducing Nuclear Factor-{kappa}B Activation and Inducible Nitric-Oxide Synthase Mol. Pharmacol., October 1, 2007; 72(4): 856 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Baker and S. J. Hill A Comparison of the Antagonist Affinities for the Gi- and Gs-Coupled States of the Human Adenosine A1-Receptor J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 218 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Lenard, V. Prpic, A. W. Adamson, R. C. Rogers, and T. W. Gettys Differential coupling of beta3A- and beta3B-adrenergic receptors to endogenous and chimeric G{alpha}s and G{alpha}i Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E704 - E715. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Iqbal, K. Kumar, L. Sun, and M. Zaidi Selective upregulation of the ADP-ribosyl cyclases CD38 and CD157 by TNF but not by RANK-L reveals differences in downstream signaling Am J Physiol Renal Physiol, September 1, 2006; 291(3): F557 - F566. [Abstract] [Full Text] [PDF] |
||||